Talis biomedical 10k

Author: oicd

August undefined, 2024

Web2 Aug 2024 · About Talis Biomedical Talis is dedicated to advancing health equity and outcomes through the delivery of accurate infectious disease testing in the moment of … Web22 Mar 2024 · Inside Talis Biomedical Corp's 10-K Annual Report: Financial - Expense Highlight Further decreases include $3.8 million for personnel related expenses and …

Talis Biomedical Corporation Expands in Chicago at Trammell …

Web26 Jan 2024 · Talis is dedicated to transforming diagnostic testing by developing and commercializing innovative products that are designed to enable accurate, low cost and rapid molecular testing for infectious diseases at the point-of-care. Web18 Feb 2024 · NEW YORK – Point-of-care infectious disease diagnostics company Talis closed its initial public offering Wednesday raising proceeds of approximately $253.9 … dr gary fisch

Infectious Disease Test Firm – Talis Biomedical Files for IPO

WebREDWOOD CITY, Calif., Nov. 03, 2024 (GLOBE NEWSWIRE) -- Talis Biomedical Corporation (Nasdaq: TLIS), a diagnostic company dedicated to advancing health equity and … Web12 Apr 2024 · Talis Biomedical Corporation operates as a molecular diagnostic company. The company is developing the Talis One system to address limitations of existing point … Web11 Feb 2024 · Talis Biomedical, which is developing diagnostic tests for COVID-19 and other infectious diseases, raised the proposed deal size for its upcoming IPO on Thursday. dr gary findley dds

Talis Awarded NIH RADx Contract to Launch Talis One™ System …

Web29 Mar 2024 · Volatility & Risk. Talis Biomedical has a beta of 1.11, indicating that its share price is 11% more volatile than the S&P 500. Comparatively, Talis Biomedical’s competitors have a beta of 1.04 ... Web12 Feb 2024 · Talis Biomedical Corporation has raised ~$220.8M by pricing its upsized initial public offering of 13.8M common shares at $16/share, high end of the estimated … enriching presentations for childrenWeb8 Feb 2024 · Talis Biomedical has filed to raise $150 million in an IPO. The firm is developing a diagnostic test for the virus and other health condition detection, including … enriching richmond county

"Web51 to 200 Employees. Founded: 2010. Type: Company - Public (TLIS) Industry: Biotech & Pharmaceuticals. Revenue: Unknown / Non-Applicable. Because infectious disease … " - Talis biomedical 10k

Talis biomedical 10k

Point-of-Care Diagnostic Testing Talis - Talis Biomedical

Web27 Jun 2024 · A Q&A with Talis Capital as it raises $100m for 2024 and hits its 10th year Mike Butcher @ mikebutcher / 11:00 PM PDT • June 26, 2024 Comment TechCrunch Early Stage April 20, 2024 Boston, MA... WebA trio of healthcare companies closed out the week’s action in the IPO market. Talis Biomedical Decibel Therapeutics and NexImmune made their debuts, with Talis’s stock …

Did you know?

Web12 Nov 2024 · About Talis Talis is dedicated to transforming diagnostic testing by developing and commercializing innovative products that are designed to enable … WebTalis Announces Fourth Quarter and Full Year 2024 Financial Results. REDWOOD CITY, Calif., March 22, 2024 (GLOBE NEWSWIRE) -- Talis Biomedical Corporation (Nasdaq: TLIS), a …

WebTalis Biomedical Annual Report 2024 Form 10-K (NASDAQ:TLIS) Published: March 30th, 2024 PDF generated by stocklight.com . UNITED STATES SECURITIES AND EXCHANGE … Web4 Apr 2024 · Based on Talis Biomedical’s latest earnings release for the quarter ending December 31, the company reported a quarterly revenue of $107 thousand and a GAAP …

Web22 Mar 2024 · FORM 8-K. CURRENT REPORT. Pursuant to Section 13 or 15 (d) of the Securities Exchange Act of 1934. Date of Report (Date of earliest event reported): March … WebTalis Biomedical Corporation operates as a molecular diagnostic company. The company is developing the Talis One system to address limitations of existing point-of-care …

Web13 Apr 2024 · NASDAQ:TLIS Talis Biomedical - TLIS News Today $0.48 0.00 (0.00%) (As of 04/5/2024 12:00 AM ET) Compare Today's Range $0.48 $0.50 50-Day Range $0.48 $0.64 52-Week Range $0.42 $1.40 Volume 13,912 shs Average Volume 94,677 shs Market Capitalization $12.90 million P/E Ratio N/A Dividend Yield N/A Price Target N/A Profile …

Web22 Mar 2024 · 2024 FY Annual report, 10-K SEC filing by Talis Biomedical on 22 Mar 23, 4:28pm dr gary figiel faxWeb27 Mar 2024 · -13.10k / -100.00%: 0.00: Data from 31 Dec 2024 ... Income statement (USD) Year on year Talis Biomedical Corp had revenues fall -41.27% from 8.19m to 4.81m, … dr gary fisch cardiologist indianapolisWeb5 Sep 2014 · Director of Chip Technology. Jan 2015 - Oct 20243 years 10 months. - Established pilot production for one of the company's core technologies, including plastic manufacturing, secondary operation ... enriching relationships mission valleyWebAt Talis, we are pioneering science and technology to diagnose infectious disease rapidly, accurately, and directly at the point of care. Fueled by excellence and clinical rigor, we’re … enriching our worship great litanyWeb30 Aug 2024 · About Talis Biomedical Talis is dedicated to transforming diagnostic testing by developing and commercializing innovative products that are designed to enable accurate, low cost, and rapid ... enriching relationships that matter mostWeb21 Mar 2024 · Talis Biomedical has 1 employees across 3 locations and $3.98 m in annual revenue in FY 2024. See insights on Talis Biomedical including office locations, … enriching scholarshipWeb12 Aug 2024 · On August 12, 2024, Talis Biomedical Corporation (the "Company") filed a request with the United States Food and Drug Administration (the "FDA") to revoke the … dr gary fischer pittsburgh pa